161 related articles for article (PubMed ID: 26202434)
1. Hepatic Clearance Prediction of Nine Human Immunodeficiency Virus Protease Inhibitors in Rat.
De Bruyn T; Augustijns PF; Annaert PP
J Pharm Sci; 2016 Feb; 105(2):846-853. PubMed ID: 26202434
[TBL] [Abstract][Full Text] [Related]
2. Clearance Prediction of HIV Protease Inhibitors in Man: Role of Hepatic Uptake.
De Bruyn T; Stieger B; Augustijns PF; Annaert PP
J Pharm Sci; 2016 Feb; 105(2):854-863. PubMed ID: 26213315
[TBL] [Abstract][Full Text] [Related]
3. Clearance and clearance inhibition of the HIV-1 protease inhibitors ritonavir and saquinavir in sandwich-cultured rat hepatocytes and rat microsomes.
Treijtel N; van Eijkeren JC; Nijmeijer S; de Greef-van der Sandt IC; Freidig AP
Toxicol In Vitro; 2009 Feb; 23(1):185-93. PubMed ID: 19038324
[TBL] [Abstract][Full Text] [Related]
4. Verapamil hepatic clearance in four preclinical rat models: towards activity-based scaling.
Nicolaï J; De Bruyn T; Van Veldhoven PP; Keemink J; Augustijns P; Annaert P
Biopharm Drug Dispos; 2015 Oct; 36(7):462-80. PubMed ID: 25963583
[TBL] [Abstract][Full Text] [Related]
5. Transport-Metabolism Interplay of Atazanavir in Rat Hepatocytes.
Nicolaï J; De Bruyn T; Thevelin L; Augustijns P; Annaert P
Drug Metab Dispos; 2016 Mar; 44(3):389-97. PubMed ID: 26712820
[TBL] [Abstract][Full Text] [Related]
6. Hepatic microsome studies are insufficient to characterize in vivo hepatic metabolic clearance and metabolic drug-drug interactions: studies of digoxin metabolism in primary rat hepatocytes versus microsomes.
Lam JL; Benet LZ
Drug Metab Dispos; 2004 Nov; 32(11):1311-6. PubMed ID: 15483198
[TBL] [Abstract][Full Text] [Related]
7. Species differences in the pharmacokinetics and metabolism of indinavir, a potent human immunodeficiency virus protease inhibitor.
Lin JH; Chiba M; Balani SK; Chen IW; Kwei GY; Vastag KJ; Nishime JA
Drug Metab Dispos; 1996 Oct; 24(10):1111-20. PubMed ID: 8894513
[TBL] [Abstract][Full Text] [Related]
8. Investigation of the rate-determining process in the hepatic elimination of HMG-CoA reductase inhibitors in rats and humans.
Watanabe T; Kusuhara H; Maeda K; Kanamaru H; Saito Y; Hu Z; Sugiyama Y
Drug Metab Dispos; 2010 Feb; 38(2):215-22. PubMed ID: 19875501
[TBL] [Abstract][Full Text] [Related]
9. In vivo clearance of ethoxycoumarin and its prediction from In vitro systems. Use Of drug depletion and metabolite formation methods in hepatic microsomes and isolated hepatocytes.
Carlile DJ; Stevens AJ; Ashforth EI; Waghela D; Houston JB
Drug Metab Dispos; 1998 Mar; 26(3):216-21. PubMed ID: 9492383
[TBL] [Abstract][Full Text] [Related]
10. The impact of solute carrier (SLC) drug uptake transporter loss in human and rat cryopreserved hepatocytes on clearance predictions.
Lundquist P; Lööf J; Sohlenius-Sternbeck AK; Floby E; Johansson J; Bylund J; Hoogstraate J; Afzelius L; Andersson TB
Drug Metab Dispos; 2014 Mar; 42(3):469-80. PubMed ID: 24396146
[TBL] [Abstract][Full Text] [Related]
11. Prediction of in vivo rat biliary drug clearance from an in vitro hepatocyte efflux model.
Lundquist P; Lööf J; Fagerholm U; Sjögren I; Johansson J; Briem S; Hoogstraate J; Afzelius L; Andersson TB
Drug Metab Dispos; 2014 Mar; 42(3):459-68. PubMed ID: 24396143
[TBL] [Abstract][Full Text] [Related]
12. Rate-limiting steps in hepatic drug clearance: comparison of hepatocellular uptake and metabolism with microsomal metabolism of saquinavir, nelfinavir, and ritonavir.
Parker AJ; Houston JB
Drug Metab Dispos; 2008 Jul; 36(7):1375-84. PubMed ID: 18426953
[TBL] [Abstract][Full Text] [Related]
13. Substrate depletion approach for determining in vitro metabolic clearance: time dependencies in hepatocyte and microsomal incubations.
Jones HM; Houston JB
Drug Metab Dispos; 2004 Sep; 32(9):973-82. PubMed ID: 15319339
[TBL] [Abstract][Full Text] [Related]
14. In vitro-in vivo correlation for low-clearance compounds using hepatocyte relay method.
Di L; Atkinson K; Orozco CC; Funk C; Zhang H; McDonald TS; Tan B; Lin J; Chang C; Obach RS
Drug Metab Dispos; 2013 Dec; 41(12):2018-23. PubMed ID: 23857891
[TBL] [Abstract][Full Text] [Related]
15. Prediction of the hepatic and renal clearance of transporter substrates in rats using in vitro uptake experiments.
Watanabe T; Maeda K; Kondo T; Nakayama H; Horita S; Kusuhara H; Sugiyama Y
Drug Metab Dispos; 2009 Jul; 37(7):1471-9. PubMed ID: 19364828
[TBL] [Abstract][Full Text] [Related]
16. Prediction of human hepatic clearance from in vivo animal experiments and in vitro metabolic studies with liver microsomes from animals and humans.
Naritomi Y; Terashita S; Kimura S; Suzuki A; Kagayama A; Sugiyama Y
Drug Metab Dispos; 2001 Oct; 29(10):1316-24. PubMed ID: 11560875
[TBL] [Abstract][Full Text] [Related]
17. Predictions of bisphenol A hepatic clearance in the isolated perfused rat liver (IPRL): impact of albumin binding and of co-administration with naproxen.
Bounakta S; Bteich M; Mantha M; Poulin P; Haddad S
Xenobiotica; 2018 Feb; 48(2):135-147. PubMed ID: 28277163
[TBL] [Abstract][Full Text] [Related]
18. Mechanistic insights from comparing intrinsic clearance values between human liver microsomes and hepatocytes to guide drug design.
Di L; Keefer C; Scott DO; Strelevitz TJ; Chang G; Bi YA; Lai Y; Duckworth J; Fenner K; Troutman MD; Obach RS
Eur J Med Chem; 2012 Nov; 57():441-8. PubMed ID: 22840492
[TBL] [Abstract][Full Text] [Related]
19. Strategies to improve the prediction accuracy of hepatic intrinsic clearance of three antidiabetic drugs: Application of the extended clearance concept and consideration of the effect of albumin on CYP2C metabolism and OATP1B-mediated hepatic uptake.
Fujino R; Hashizume K; Aoyama S; Maeda K; Ito K; Toshimoto K; Lee W; Ninomiya SI; Sugiyama Y
Eur J Pharm Sci; 2018 Dec; 125():181-192. PubMed ID: 30287410
[TBL] [Abstract][Full Text] [Related]
20. The Phenomenon of Albumin-Mediated Hepatic Uptake of Organic Anion Transport Polypeptide Substrates: Prediction of the In Vivo Uptake Clearance from the In Vitro Uptake by Isolated Hepatocytes Using a Facilitated-Dissociation Model.
Miyauchi S; Masuda M; Kim SJ; Tanaka Y; Lee KR; Iwakado S; Nemoto M; Sasaki S; Shimono K; Tanaka Y; Sugiyama Y
Drug Metab Dispos; 2018 Mar; 46(3):259-267. PubMed ID: 29298773
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
